Page last updated: 2024-09-04

4-methoxyhonokiol and Cancer of Cervix

4-methoxyhonokiol has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bak, Y; Ham, SY; Hong, J; Hyun, S; Kim, MS; Lee, DH; Song, YS; Yoon, DY	1

Other Studies

1 other study(ies) available for 4-methoxyhonokiol and Cancer of Cervix

Article	Year
Peroxisome proliferator-activated receptor-gamma agonist 4-O-methylhonokiol induces apoptosis by triggering the intrinsic apoptosis pathway and inhibiting the PI3K/Akt survival pathway in SiHa human cervical cancer cells. Journal of microbiology and biotechnology, 2015, Volume: 25, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Caspase 3; Caspase 9; Cell Line, Tumor; Female; Humans; Lignans; Mitochondria; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; Signal Transduction; Uterine Cervical Neoplasms	2015

Article

Year

Peroxisome proliferator-activated receptor-gamma agonist 4-O-methylhonokiol induces apoptosis by triggering the intrinsic apoptosis pathway and inhibiting the PI3K/Akt survival pathway in SiHa human cervical cancer cells.

Journal of microbiology and biotechnology, 2015, Volume: 25, Issue:3

Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Caspase 3; Caspase 9; Cell Line, Tumor; Female; Humans; Lignans; Mitochondria; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; Signal Transduction; Uterine Cervical Neoplasms

2015